Clinical Trials Logo

Filter by:
NCT ID: NCT03755492 Terminated - Post Prostatectomy Clinical Trials

Initiative to Minimize Disparities in Postoperative Prostate Cancer Care

Start date: April 1, 2019
Phase:
Study type: Observational

Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community. The investigators routinely see patients who cannot afford absorbent pads after prostate surgery, which helps with quality of life secondary to urinary incontinence. The investigators will provide absorbent pads to participants who would be unable to afford them. The investigators hypothesize that providing absorbent pads for 6 months will result in improved quality of life in regards to management of urinary incontinence after radical prostatectomy.

NCT ID: NCT03755362 Terminated - Clinical trials for Mild Cognitive Impairment

Dental Carotid Cognitive Study

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

Periodontal Disease (PD) is present in 60+% of adults >65 years and is associated with tobacco smoking, diabetes, and atherosclerosis that worsen inflammation, comorbidities common in older people with mild to moderate cognitive impairment (MCI). Older MCI patients are prone to poor oral hygiene and dental health, which if untreated worsens inflammation-mediated brain and nervous system function, and accelerates progression to dementia. Asymptomatic carotid artery stenosis (ACAS) is often a silent disease detected in only ~10% of older adults, and may have a strong association with MCI. This study examines the effects of intensive therapy for periodontitis on cognition in high-risk older people with ACAS. Results could highlight PD as a readily modifiable risk factor for dementia.

NCT ID: NCT03753789 Terminated - Liver Cancer Clinical Trials

Ablation Confirmation Study

Start date: November 5, 2019
Phase: N/A
Study type: Interventional

Prospective, single-arm, multicenter study that will generate clinical data using the NEUWAVE MicroWave Ablation System with AC (Ablation Confirmation) software in patients undergoing ablation of a soft tissue liver lesion.

NCT ID: NCT03752632 Terminated - Clinical trials for Difficult-to-access Veins for Intravenous Cannulation

Veinplicity for Improved Venous Access: The VIVA Trial

Start date: November 1, 2018
Phase: Phase 3
Study type: Interventional

This study will assess the safety and effectiveness of the Veinplicity device to improve the visualization and palpability of difficult-to-access veins for intravenous cannulation.

NCT ID: NCT03752242 Terminated - Acne Vulgaris Clinical Trials

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

Start date: January 3, 2019
Phase: Phase 2
Study type: Interventional

This is an exploratory Phase 2 trial of BMX-010 in patients with Acne Vulgaris which will be conducted in two parts.

NCT ID: NCT03752203 Terminated - Clinical trials for Pediatric Neurosurgical Tumors

Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors

Start date: August 11, 2021
Phase: N/A
Study type: Interventional

Sodium fluorescein, which has been shown to be useful for intraoperative guidance regarding the resection of adult neurosurgical tumors, can aid the resection of pediatric neurosurgical tumors.

NCT ID: NCT03752177 Terminated - Solid Tumor Clinical Trials

A Study of LY3415244 in Participants With Advanced Solid Tumors

Start date: November 22, 2018
Phase: Phase 1
Study type: Interventional

The goal of this study is to evaluate the safety of LY3415244, a PD-L1/TIM-3 bispecific antibody, administered as monotherapy to participants with advanced solid tumors.

NCT ID: NCT03752099 Terminated - Clinical trials for Metastatic Castration Resistant Prostate Cancer

To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer

Start date: January 18, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer who have failed a novel androgen blocking agent therapy (mCRPC). Phase 2 - To estimate the PSA50 response rate, defined as a decline in PSA to ≥50% of baseline level, confirmed with a second measurement at least 3 weeks apart (PCWG3).

NCT ID: NCT03752073 Terminated - Induction of Labor Clinical Trials

Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix

CORC
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This is a randomized prospective trial of two mechanical methods of pre-induction cervical ripening agents.

NCT ID: NCT03751813 Terminated - Clinical trials for Gestational Diabetes

Baby Bump Lifestyle Intervention Supplement Study

Baby BLISS
Start date: March 21, 2019
Phase: N/A
Study type: Interventional

The overall purpose of this study is to examine how natural supplements can mediate the effects of stress on fetal development during pregnancy.